Items where authors include "Hanby, AM"

Article

Stevens, W, Farrow, IM, Georgiou, L et al. (9 more authors) (2021) Breast tumour volume and blood flow measured by MRI after one cycle of epirubicin and cyclophosphamide-based neoadjuvant chemotherapy as predictors of pathological response. The British Journal of Radiology. 20201396-. ISSN 0007-1285

Broad, RV, Jones, SJ, Teske, MC et al. (4 more authors) (2021) Inhibition of interferon-signalling halts cancer-associated fibroblast-dependent protection of breast cancer cells from chemotherapy. British Journal of Cancer, 124. pp. 1110-1120. ISSN 0007-0920

Al Amri, WS, Baxter, DE, Hanby, AM orcid.org/0000-0001-7966-1570 et al. (4 more authors) (2020) Identification of candidate mediators of chemoresponse in breast cancer through therapy-driven selection of somatic variants. Breast Cancer Research and Treatment, 183 (3). pp. 607-616. ISSN 0167-6806

Verma, R, Hanby, AM orcid.org/0000-0001-7966-1570, Horgan, K et al. (4 more authors) (2020) Levels of different subtypes of tumour-infiltrating lymphocytes correlate with each other, with matched circulating lymphocytes, and with survival in breast cancer. Breast Cancer Research and Treatment, 183 (1). pp. 49-59. ISSN 0167-6806

Al Amri, WS, Allinson, LM, Baxter, DE orcid.org/0000-0001-8830-6802 et al. (7 more authors) (2020) Genomic and expression analyses define MUC17 and PCNX1 as predictors of chemotherapy response in breast cancer. Molecular Cancer Therapeutics, 19 (3). pp. 945-955. ISSN 1535-7163

Tulotta, C, Lefley, DV, Freeman, K et al. (16 more authors) (2019) Endogenous production of IL-1B by breast cancer cells drives metastasis and colonisation of the bone microenvironment. Clinical Cancer Research, 25 (9). pp. 2769-2782. ISSN 1078-0432

Westbrook, JA, Wood, SL, Cairns, DA orcid.org/0000-0002-2338-0179 et al. (14 more authors) (2019) Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer. The Journal of pathology, 247 (3). pp. 381-391. ISSN 0022-3417

Baxter, DE orcid.org/0000-0001-8830-6802, Kim, B, Hanby, AM orcid.org/0000-0001-7966-1570 et al. (3 more authors) (2018) Neoadjuvant Endocrine Therapy in Breast Cancer Upregulates the Cytotoxic Drug Pump ABCG2/BCRP, and May Lead to Resistance to Subsequent Chemotherapy. Clinical Breast Cancer, 18 (6). pp. 481-488. ISSN 1526-8209

Coulson-Gilmer, C, Humphries, MP, Sundara Rajan, S et al. (14 more authors) (2018) Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer. The Journal of Pathology: Clinical Research, 4 (4). pp. 241-249. ISSN 2056-4538

Lindsay, CR, Shaw, EC, Blackhall, F et al. (26 more authors) (2018) Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme. Esmo Open, 3 (6). e000408. ISSN 2059-7029

Dessauvagie, BF, Lee, AHS, Meehan, K et al. (8 more authors) (2018) Interobserver variation in the diagnosis of fibroepithelial lesions of the breast: a multicentre audit by digital pathology. Journal of Clinical Pathology, 71 (8). pp. 672-679. ISSN 0021-9746

Baldacchino, S, Wastall, LM, Saliba, C et al. (6 more authors) (2017) CIP2A expression predicts recurrences of tamoxifen-treated breast cancer. Tumour Biology, 39 (10). ISSN 1010-4283

Thomas, JS, Hanby, AM orcid.org/0000-0001-7966-1570, Russell, N et al. (10 more authors) (2017) The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer. Breast Cancer Research and Treatment, 163 (1). pp. 63-69. ISSN 0167-6806

Humphries, MP orcid.org/0000-0003-1306-7012, Sundara Rajan, S, Honarpisheh, H et al. (18 more authors) (2017) Characterisation of male breast cancer: a descriptive biomarker study from a large patient series. Scientific Reports, 7. 45293. ISSN 2045-2322

Lawson, J, Robinson-Vyas, RJ, McQuillan, JP et al. (11 more authors) (2017) Crowdsourcing for translational research: analysis of biomarker expression using cancer microarrays. British Journal of Cancer, 116 (2). pp. 237-245. ISSN 0007-0920

Millican-Slater, RA, Sayers, CD, Hanby, AM et al. (1 more author) (2016) Expression of phosphorylated eIF4E-binding protein 1, but not of eIF4E itself, predicts survival in male breast cancer. British Journal of Cancer, 115 (3). pp. 339-345. ISSN 0007-0920

Westbrook, JA, Cairns, DA orcid.org/0000-0002-2338-0179, Peng, J et al. (10 more authors) (2016) CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment. JNCI: Journal of the National Cancer Institute, 108 (4). ISSN 0027-8874

Patel, F, Achuthan, R, Hyklova, L et al. (2 more authors) (2016) Management of breast cancer in an Asian man with post-traumatic stress disorder: a case report. Journal of Medical Case Reports, 10 (77). ISSN 1752-1947

Booth, ME, Nash, CE, Roberts, NP et al. (4 more authors) (2015) 3-D tissue modelling and virtual pathology as new approaches to study ductal carcinoma in situ. Alternatives to Laboratory Animals, 43 (6). pp. 377-383. ISSN 0261-1929

Romanska, HM, Potemski, P, Krakowska, M et al. (8 more authors) (2015) Lack of CD151/integrin alpha 3 beta 1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers. British Journal of Cancer, 113 (9). pp. 1350-1357. ISSN 0007-0920

Smith, L, Baxter, EW, Chambers, PA et al. (8 more authors) (2015) Down-Regulation of miR-92 in Breast Epithelial Cells and in Normal but Not Tumour Fibroblasts Contributes to Breast Carcinogenesis. PLoS ONE, 10 (10). e0139698. ISSN 1932-6203

Kim, B, Stephen, SL, Hanby, AM et al. (9 more authors) (2015) Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy. BMC Cancer, 15. 634. ISSN 1471-2407

Abraham, S, Scarcia, M, Bagshaw, R et al. (15 more authors) (2015) A Rac/Cdc42 exchange factor complex promotes formation of lateral filopodia and blood vessel lumen morphogenesis. Nature Communications, 6. 7286. ISSN 2041-1723

Downey, CL, Simpkins, SA, Holliday, DL et al. (5 more authors) (2015) Reponse to: comment on, 'Tumour-stroma ratio (TSR) in oestrogen-positive breast cancer patients'. British Journal of Cancer, 112 (11). 1833 - 1834. ISSN 0007-0920

Rea, D, Francis, A, Hanby, AM et al. (9 more authors) (2015) Inflammatory breast cancer: Time to standardise diagnosis assessment and management, and for the joining of forces to facilitate effective research. British Journal of Cancer, 112 (9). 1613 - 1615. ISSN 0007-0920

Nash, CE, Mavria, G, Baxter, EW et al. (7 more authors) (2015) Development and characterisation of a 3D multi-cellular in vitro model of normal human breast: a tool for cancer initiation studies. Oncotarget.

Langlands, FE, Dodwell, D, Hanby, AM et al. (6 more authors) (2014) PSMD9 expression predicts radiotherapy response in breast cancer. Molecular Cancer, 13. 73. ISSN 1476-4598

Verghese, ET, Drury, R, Green, CA et al. (10 more authors) (2013) MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion. The Journal of Pathology, 231 (3). pp. 388-399. ISSN 0022-3417